Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease 2023-10-02 08:30
WuXi Biologics and Boostimmune Sign MOU for Exclusive Research and Discovery Services 2023-08-11 08:30
WuXi Biologics to Increase Manufacturing Capacity in Germany 2023-06-01 16:49
WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations 2023-05-22 16:30
WuXi Biologics Announces Manufacturing Partnership with InflaRx to Advance Gohibic for the Treatment of Certain Critically Ill COVID-19 patients 2023-05-16 16:00
WuXi Biologics Releases 2022 ESG Report Detailing Its Continued Commitment to Sustainability 2023-04-28 14:43
WuXi Biologics Congratulates Amicus Therapeutics on European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease 2023-03-28 20:11
WuXi Biologics Reports Remarkable 2022 Annual Results 2023-03-22 20:09
WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers 2023-01-05 08:30
WuXi Biologics (Shanghai) Co., Ltd. Removed from the U.S. Commerce Department's Unverified List 2022-12-16 08:44
WuXi Biologics Provides Corporate Updates 2022-10-27 22:13
WuXi Biologics Announces GMP Release of 48,000L Commercial Drug Substance Manufacturing Facility in Hebei, China 2022-10-26 12:30
WuXi Biologics Released a New cGMP Drug Product Manufacturing Facility to Support End-to-End Services for Diversified Modalities 2022-10-24 08:30
WuXi Biologics Receives "Best CDMO Award of the Year" 2022-10-14 09:00
WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody 2022-10-12 09:00
WuXi Biologics Co., Ltd. Removed from Unverified List 2022-10-10 07:55
WuXi Biologics Topped Off the Steel on its Commercial Biomanufacturing Facility in Worcester, Massachusetts 2022-09-29 10:41
WuXi Biologics' Drug Substance and Drug Product Facilities Again Approved by U.S. FDA and EMA 2022-09-20 10:48
WuXi Biologics Announces GMP Release of Its First North American Biomanufacturing Facility in Cranbury, New Jersey 2022-08-31 20:00
WuXi Biologics Reports Strong 2022 Interim Results 2022-08-17 21:32
1 2 3 4 5 9